AMNEAL PHARMACEUTICALS, INC. Fair Value of Assets Acquired
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Fair Value of Assets Acquired of $0 for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-05.
Discontinued › Cash Flow
us-gaap:FairValueOfAssetsAcquired · last filed 2019-08-05
- 2019-06-30: Fair Value of Assets Acquired 6 month $0.00.
- 2018-06-30: Fair Value of Assets Acquired 6 month $10.00M.
- 2017-06-30: Fair Value of Assets Acquired 6 month $19.50M.
| Period end | Fair Value of Assets Acquired 6 month |
|---|---|
| 2019-06-30 | $0.00 10-Q · filed 2019-08-05 |
| 2018-06-30 | $10.00M 10-Q · filed 2019-08-05 |
| 2017-06-30 | $19.50M 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |